Company: VERA
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001193125-25-266881
Chunk: 1

Company: Vera Therapeutics, Inc.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
31, 2024, respectively

     64

     64

     Additional paid-in capital

     1,067,703

     1,037,948

     Accumulated other comprehensive income

     881

     393

     Accumulated deficit

     (669,768
     )

     (461,250
     )

     Total stockholders’ equity

     398,880

     577,155

     Total liabilities and stockholders’ equity
      
     $
     517,503

     $
     655,681

The accompanying notes are an integral part of these unaudited condensed financial statements.